Skip to Content

Medications for Cerebral Arteriography

Drugs associated with Cerebral Arteriography

The following drugs and medications are in some way related to, or used in the treatment of this condition.

What is Cerebral Arteriography: Cerebral arteriography is examination of the blood vessels in and around the brain on an x-ray, by injecting the blood vessels with an x-ray visible dye.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
Visipaque Rx B N Add review Add

Generic name: iodixanol systemic

Drug class: non-ionic iodinated contrast media

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Ultravist Rx B N Add review Add

Generic name: iopromide systemic

Drug class: non-ionic iodinated contrast media

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Oxilan Rx B N Add review Add

Generic name: ioxilan systemic

Drug class: non-ionic iodinated contrast media

For consumers: interactions, side effects

For professionals: Prescribing Information

 
ioversol Rx B N Add review Add

Generic name: ioversol systemic

Brand names:  Optiray 350, Optiray 320, Optiray 160, Optiray 240, Optiray 300

Drug class: non-ionic iodinated contrast media

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Optiray 350 Rx B N Add review Add

Generic name: ioversol systemic

Drug class: non-ionic iodinated contrast media

For consumers: dosage, interactions, side effects

 
iopromide Rx B N Add review Add

Generic name: iopromide systemic

Brand name:  Ultravist

Drug class: non-ionic iodinated contrast media

For consumers: interactions, side effects

For professionals: A-Z Drug Facts

 
Omnipaque 300 Rx B N Add review Add

Generic name: iohexol systemic

Drug class: non-ionic iodinated contrast media

For consumers: interactions, side effects

 
iodixanol Rx B N Add review Add

Generic name: iodixanol systemic

Brand name:  Visipaque

Drug class: non-ionic iodinated contrast media

For consumers: dosage, interactions, side effects

 
Optiray 320 Rx B N Add review Add

Generic name: ioversol systemic

Drug class: non-ionic iodinated contrast media

For consumers: dosage, interactions, side effects

 
iohexol Rx B N Add review Add

Generic name: iohexol systemic

Brand names:  Omnipaque 300, Omnipaque 140, Omnipaque 180, Omnipaque 240, Omnipaque 350, Omnipaque Flexipak

Drug class: non-ionic iodinated contrast media

For consumers: interactions, side effects

For professionals: Prescribing Information

 
Omnipaque 140 Rx B N Add review Add

Generic name: iohexol systemic

Drug class: non-ionic iodinated contrast media

For consumers: interactions, side effects

 
Omnipaque 180 Rx B N Add review Add

Generic name: iohexol systemic

Drug class: non-ionic iodinated contrast media

For consumers: interactions, side effects

 
Omnipaque 240 Rx B N Add review Add

Generic name: iohexol systemic

Drug class: non-ionic iodinated contrast media

For consumers: interactions, side effects

 
Omnipaque 350 Rx B N Add review Add

Generic name: iohexol systemic

Drug class: non-ionic iodinated contrast media

For consumers: interactions, side effects

 
Omnipaque Flexipak Rx B N Add review Add

Generic name: iohexol systemic

Drug class: non-ionic iodinated contrast media

For consumers: interactions, side effects

 
Optiray 160 Rx B N Add review Add

Generic name: ioversol systemic

Drug class: non-ionic iodinated contrast media

For consumers: dosage, interactions, side effects

 
Optiray 240 Rx B N Add review Add

Generic name: ioversol systemic

Drug class: non-ionic iodinated contrast media

For consumers: dosage, interactions, side effects

 
Optiray 300 Rx B N Add review Add

Generic name: ioversol systemic

Drug class: non-ionic iodinated contrast media

For consumers: dosage, interactions, side effects

 
Showing all

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N The drug is not subject to the Controlled Substances Act.
1 The drug has a high potential for abuse. The drug has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug under medical supervision.
2 The drug has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
3 The drug has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
4 The drug has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
5 The drug has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide